抗バイオフィルム創傷被覆材市場レポート：2030年までの動向、予測、競合分析

抗バイオフィルム創傷被覆材の動向と予測

世界の抗バイオフィルム創傷被覆材市場は、2024年から2030年までのCAGRが9.2%で、2030年までに推定14億米ドルに達すると予測されています。この市場の主な促進要因は、糖尿病、がん、自己免疫疾患などの持続的な疾患の有病率の上昇と、世界の外科手術件数の急増に伴う創傷ケア製品に対する需要の高まりです。世界の抗バイオフィルム創傷被覆材市場の将来は、病院・診療所、外科センター市場における機会によって有望視されています。

抗バイオフィルム創傷被覆材のセグメント別予測

本調査では、抗バイオフィルム創傷被覆材の世界市場について、メカニズム別、用途別、最終用途別、地域別に予測しています。

抗バイオフィルム創傷被覆材市場の洞察

Lucintelでは、慢性創傷の有病率の増加と手術件数の増加により、予測期間中、化学薬品が最大のセグメントであり続けると予測しています。

この市場の中では、スポーツ関連傷害、火傷、外傷の増加により、病院が引き続き大きなセグメントとなると思われます。

北米は、スポーツ傷害の発生率の増加と主要企業の存在により、予測期間中最大の地域であり続けると思われます。

よくある質問

Q1.市場規模は：

A1.世界の抗バイオフィルム創傷被覆材市場は、2030年までに推定14億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.抗バイオフィルム創傷被覆材の世界市場は、2024年から2030年にかけてCAGR 9.2%で成長する見込みです。

Q3.市場の成長に影響を与える主な促進要因は：

A3.この市場の主な促進要因は、糖尿病、がん、自己免疫疾患などの持続的な疾患の有病率の上昇と、世界の外科手術件数の急増に伴う創傷ケア製品に対する需要の増加です。

Q4.市場の主要セグメントは：

A4.抗バイオフィルム創傷被覆材市場の将来は、病院・診療所および外科センター市場における機会により有望です。

Q5.市場の主要企業は：

A5.抗バイオフィルム創傷被覆材の主要企業は以下の通りです：

• ConvaTec
• Smith & Nephew
• Urgo Medical
• Coloplast
• 3M
• Molnlycke Health Care
• Imbed Biosciences
• Next Science
• B. Braun Melsungen
• Lohmann & Rauscher

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、慢性創傷の有病率の増加と手術件数の増加により、化学薬品が予測期間中最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は、スポーツ傷害の増加や主要企業の存在により、予測期間中も最大の地域です。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の抗バイオフィルム創傷被覆材市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の抗バイオフィルム創傷被覆材市場の動向（2018-2023年）と予測（2024-2030年）
• メカニズム別世界の抗バイオフィルム創傷被覆材市場
  • 物理的
  • 化学的
  • 生物学的
• 用途別抗バイオフィルム創傷被覆材の世界市場
  • 慢性創傷
  • 急性創傷
• 最終用途別世界の抗バイオフィルム創傷被覆材市場
  • 病院・診療所
  • 外科センター
  • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別世界の抗バイオフィルム創傷被覆材市場
• 北米の抗バイオフィルム創傷被覆材市場
• 欧州の抗バイオフィルム創傷被覆材市場
• アジア太平洋地域の抗バイオフィルム創傷被覆材市場
• その他地域抗バイオフィルム創傷被覆材市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • メカニズム別世界の抗バイオフィルム創傷被覆材市場の成長機会
  • 世界の抗バイオフィルム創傷被覆材市場における用途別の成長機会
  • 最終用途別世界の抗バイオフィルム創傷被覆材市場の成長機会
  • 地域別の世界の抗バイオフィルム創傷被覆材市場の成長機会
• 世界の抗バイオフィルム創傷被覆材市場の新たな動向
• 戦略分析
  • 新製品の開発
  • 世界の抗バイオフィルム創傷被覆材市場の生産能力拡大
  • 世界の抗バイオフィルム創傷被覆材市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• ConvaTec
• Smith & Nephew
• Urgo Medical
• Coloplast
• 3M
• Molnlycke Health Care
• Imbed Biosciences
• Next Science
• B. Braun Melsungen
• Lohmann & Rauscher

Anti-Biofilm Wound Dressing Trends and Forecast

The future of the global anti-biofilm wound dressing market looks promising with opportunities in the hospitals and clinics and surgical centers markets. The global anti-biofilm wound dressing market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 9.2% from 2024 to 2030. The major drivers for this market are rising prevalence of persistent conditions like diabetes, cancer, and autoimmune disorders and growing demand for wound care products along with surging number of surgical procedures around the globe.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Anti-Biofilm Wound Dressing by Segment

The study includes a forecast for the global anti-biofilm wound dressing by mode of mechanism, application, end use, and region.

Anti-Biofilm Wound Dressing Market by Mode of Mechanism [Shipment Analysis by Value from 2018 to 2030]:

• Physical
• Chemical
• Biological

Anti-Biofilm Wound Dressing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Chronic Wounds
• Acute Wounds

Anti-Biofilm Wound Dressing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals And Clinics
• Surgical Centers
• Others

Anti-Biofilm Wound Dressing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Anti-Biofilm Wound Dressing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies anti-biofilm wound dressing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anti-biofilm wound dressing companies profiled in this report include-

• ConvaTec
• Smith & Nephew
• Urgo Medical
• Coloplast
• 3M
• Molnlycke Health Care
• Imbed Biosciences
• Next Science
• B. Braun Melsungen
• Lohmann & Rauscher

Anti-Biofilm Wound Dressing Market Insights

Lucintel forecasts that chemical will remain the largest segment over the forecast period due to increasing prevalence of chronic wounds and rising number of surgeries.

Within this market, hospitals will remain larger segment due to rising sports-related injuries, burn and trauma cases.

North America will remain the largest region over the forecast period due to growing incidence of sports injuries and presence of key players in the region.

Features of the Global Anti-Biofilm Wound Dressing Market

Market Size Estimates: Anti-biofilm wound dressing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Anti-biofilm wound dressing market size by mode of mechanism, application, end use, and region in terms of value ($B).

Regional Analysis: Anti-biofilm wound dressing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different modes of mechanism, applications, end uses, and regions for the anti-biofilm wound dressing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the anti-biofilm wound dressing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the anti-biofilm wound dressing market size?

Answer: The global anti-biofilm wound dressing market is expected to reach an estimated $1.4 billion by 2030.

Q2. What is the growth forecast for anti-biofilm wound dressing market?

Answer: The global anti-biofilm wound dressing market is expected to grow with a CAGR of 9.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the anti-biofilm wound dressing market?

Answer: The major drivers for this market are rising prevalence of persistent conditions like diabetes, cancer, and autoimmune disorders and growing demand for wound care products along with surging number of surgical procedures around the globe.

Q4. What are the major segments for anti-biofilm wound dressing market?

Answer: The future of the anti-biofilm wound dressing market looks promising with opportunities in the hospitals and clinics and surgical centers markets.

Q5. Who are the key anti-biofilm wound dressing market companies?

Answer: Some of the key anti-biofilm wound dressing companies are as follows:

• ConvaTec
• Smith & Nephew
• Urgo Medical
• Coloplast
• 3M
• Molnlycke Health Care
• Imbed Biosciences
• Next Science
• B. Braun Melsungen
• Lohmann & Rauscher

Q6. Which anti-biofilm wound dressing market segment will be the largest in future?

Answer: Lucintel forecasts that chemical will remain the largest segment over the forecast period due to increasing prevalence of chronic wounds and rising number of surgeries.

Q7. In anti-biofilm wound dressing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing incidence of sports injuries and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the anti-biofilm wound dressing market by mode of mechanism (physical, chemical, and biological), application (chronic wounds and acute wounds), end use (hospitals and clinics, surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Anti-Biofilm Wound Dressing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Anti-Biofilm Wound Dressing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Anti-Biofilm Wound Dressing Market by Mode of Mechanism
  • 3.3.1: Physical
  • 3.3.2: Chemical
  • 3.3.3: Biological
• 3.4: Global Anti-Biofilm Wound Dressing Market by Application
  • 3.4.1: Chronic Wounds
  • 3.4.2: Acute Wounds
• 3.5: Global Anti-Biofilm Wound Dressing Market by End Use
  • 3.5.1: Hospitals and Clinics
  • 3.5.2: Surgical Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Anti-Biofilm Wound Dressing Market by Region
• 4.2: North American Anti-Biofilm Wound Dressing Market
  • 4.2.1: North American Anti-Biofilm Wound Dressing Market by Mode of Mechanism: Physical, Chemical, and Biological
  • 4.2.2: North American Anti-Biofilm Wound Dressing Market by End Use: Hospitals and Clinics, Surgical Centers, and Others
• 4.3: European Anti-Biofilm Wound Dressing Market
  • 4.3.1: European Anti-Biofilm Wound Dressing Market by Mode of Mechanism: Physical, Chemical, and Biological
  • 4.3.2: European Anti-Biofilm Wound Dressing Market by End Use: Hospitals and Clinics, Surgical Centers, and Others
• 4.4: APAC Anti-Biofilm Wound Dressing Market
  • 4.4.1: APAC Anti-Biofilm Wound Dressing Market by Mode of Mechanism: Physical, Chemical, and Biological
  • 4.4.2: APAC Anti-Biofilm Wound Dressing Market by End Use: Hospitals and Clinics, Surgical Centers, and Others
• 4.5: ROW Anti-Biofilm Wound Dressing Market
  • 4.5.1: ROW Anti-Biofilm Wound Dressing Market by Mode of Mechanism: Physical, Chemical, and Biological
  • 4.5.2: ROW Anti-Biofilm Wound Dressing Market by End Use: Hospitals and Clinics, Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Anti-Biofilm Wound Dressing Market by Mode of Mechanism
  • 6.1.2: Growth Opportunities for the Global Anti-Biofilm Wound Dressing Market by Application
  • 6.1.3: Growth Opportunities for the Global Anti-Biofilm Wound Dressing Market by End Use
  • 6.1.4: Growth Opportunities for the Global Anti-Biofilm Wound Dressing Market by Region
• 6.2: Emerging Trends in the Global Anti-Biofilm Wound Dressing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Anti-Biofilm Wound Dressing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Anti-Biofilm Wound Dressing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: ConvaTec
• 7.2: Smith & Nephew
• 7.3: Urgo Medical
• 7.4: Coloplast
• 7.5: 3M
• 7.6: Molnlycke Health Care
• 7.7: Imbed Biosciences
• 7.8: Next Science
• 7.9: B. Braun Melsungen
• 7.10: Lohmann & Rauscher